INS and type 2 diabetes mellitus: The findings suggest that GEG has the potential to alleviate type 2 diabetes-induced intestinal dysfunction, enhance insulin production, and boost beta cell number (as evidenced by the observed increase in insulin-producing beta cells detected through insulin-immunohistochemistry staining) [62].